Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study

Archives of General Psychiatry
R G McCreadieSandeep D Jaipurkar

Abstract

In south India, abnormal movements indistinguishable from tardive dyskinesia have been observed in chronically ill patients with schizophrenia who have never received antipsychotic medication. The present study, using magnetic resonance imaging, examines brain structure in such patients, in those without dyskinesia, and in normal control subjects. Chronically ill patients with schizophrenia with and without dyskinesia and controls were identified in villages south of Chennai, India (each group, n = 31). Patients' mental state was assessed by the Positive and Negative Syndrome Scale for schizophrenia, dyskinesia by the Abnormal Involuntary Movements Scale, and parkinsonism by the Simpson and Angus scale. In patients and controls, magnetic resonance imaging measured the volume of the caudate and lentiform nuclei and the lateral ventricle-hemisphere ratio. The left lentiform nucleus was significantly (11%) larger in patients with dyskinesia compared with controls, and the right lateral ventricle-hemisphere ratio was significantly (33%) larger in patients without dyskinesia compared with controls. In all 3 groups, there were significant positive correlations between age and ventricle-hemisphere ratio. In controls, but not in patien...Continue Reading

Citations

Jul 2, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Robin G McCreadieRamachandra Padmavathi
Oct 23, 2014·Epidemiology and Psychiatric Sciences·E ZampieriP Brambilla
Dec 12, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Salvador SarróPeter J McKenna
Jan 1, 2010·Indian Journal of Psychiatry·Matcheri S KeshavanBangalore N Gangadhar
Apr 27, 2011·Current Psychiatry Reports·Vladimir Lerner, Chanoch Miodownik
Sep 15, 2004·Der Nervenarzt·H Scherk, P Falkai
Jan 21, 2010·Psychological Medicine·J Moncrieff, J Leo
Apr 30, 2005·Biological Psychiatry·Linda ChangThomas Ernst
Oct 13, 2012·International Review of Psychiatry·Janardhanan C NarayanaswamyBangalore N Gangadhar
Dec 1, 2009·The Psychiatric Clinics of North America·Arman Danielyan, Henry A Nasrallah
Oct 20, 2009·Molecular and Cellular Neurosciences·Adam NowakowskiRoberto Parrilla
Apr 21, 2007·Comprehensive Psychiatry·Srinivasan TirupatiRobin G McCreadie
Sep 6, 2003·Acta Psychiatrica Scandinavica·S E ChuaP J McKenna
Jun 3, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Abdesslem KhiatYvan Boulanger
Mar 23, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Yevgeniy KuznetsovYvan Boulanger
Feb 24, 2005·Journal of Psychiatric Research·Robin G McCreadieRangaswamy Thara
Dec 6, 2005·Comprehensive Psychiatry·Srinivasan N TirupatiRobin G McCreadie
Feb 29, 2016·L'Encéphale·A-S SeigneurieF Limosin
Sep 17, 2008·Journal of Clinical Psychopharmacology·Jimmy LeeSiow-Ann Chong
Jun 6, 2009·Harvard Review of Psychiatry·Joanna Moncrieff
Apr 24, 2004·The British Journal of Psychiatry : the Journal of Mental Science·R TharaT N Srinivasan
Nov 3, 2005·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Howard C MargoleseRobert Miller
Aug 2, 2005·The British Journal of Psychiatry. Supplement·Matcheri S KeshavanChristos Pantelis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here